These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26248134)

  • 1. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes.
    Saygili E; Noor-Ebad F; Schröder JW; Mischke K; Saygili E; Rackauskas G; Marx N; Kelm M; Rana OR
    Biochem Biophys Res Commun; 2015 Sep; 465(1):119-24. PubMed ID: 26248134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
    Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K
    J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy.
    Staudt A; Eichler P; Trimpert C; Felix SB; Greinacher A
    J Am Coll Cardiol; 2007 Apr; 49(16):1684-92. PubMed ID: 17448369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
    Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A
    Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
    Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
    Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
    Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
    J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.
    Mao C; Hou X; Wang B; Chi J; Jiang Y; Zhang C; Li Z
    Stem Cell Res Ther; 2017 Jan; 8(1):18. PubMed ID: 28129792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy.
    Voigt A; Trimpert C; Bartel K; Egerer K; Kuckelkorn U; Feist E; Gericke C; Klingel K; Kandolf R; Felix SB; Baumann G; Kloetzel PM; Stangl K; Staudt A
    Basic Res Cardiol; 2010 Jul; 105(4):557-67. PubMed ID: 20336303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
    Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
    Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes.
    Christ T; Adolph E; Schindelhauer S; Wettwer E; Dobrev D; Wallukat G; Ravens U
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):445-52. PubMed ID: 15910408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.